πŸ‡ΊπŸ‡Έ FDA
Patent

US 10562886

Anti-cancer compounds

granted A61KA61K31/502A61P

Quick answer

US patent 10562886 (Anti-cancer compounds) held by The Regents of the University of California expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
39
CPC classes
A61K, A61K31/502, A61P, A61P35/00